GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Defence Therapeutics Inc (XCNQ:DTC) » Definitions » ROE % Adjusted to Book Value

Defence Therapeutics (XCNQ:DTC) ROE % Adjusted to Book Value : 0.00% (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Defence Therapeutics ROE % Adjusted to Book Value?

Defence Therapeutics's ROE % for the quarter that ended in Dec. 2023 was 0.00%. Defence Therapeutics's PB Ratio for the quarter that ended in Dec. 2023 was N/A. Defence Therapeutics's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was N/A.


Defence Therapeutics ROE % Adjusted to Book Value Historical Data

The historical data trend for Defence Therapeutics's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Defence Therapeutics ROE % Adjusted to Book Value Chart

Defence Therapeutics Annual Data
Trend Jun20 Jun21 Jun22
ROE % Adjusted to Book Value
- -1.72 -

Defence Therapeutics Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Defence Therapeutics's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Defence Therapeutics's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Defence Therapeutics's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Defence Therapeutics's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Defence Therapeutics's ROE % Adjusted to Book Value falls into.



Defence Therapeutics ROE % Adjusted to Book Value Calculation

Defence Therapeutics's ROE % Adjusted to Book Value for the fiscal year that ended in Jun. 2022 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-288.06% / N/A
=N/A

Defence Therapeutics's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Defence Therapeutics ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Defence Therapeutics's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Defence Therapeutics (XCNQ:DTC) Business Description

Traded in Other Exchanges
Address
200 Burrard Street, Suite 1680, Vancouver, BC, CAN, V6C3L6
Defence Therapeutics Inc is engaged in the development of a biological drug enhancer platform that improves the efficacy and safety of a multitude of biological/biosimilar-based pharmaceuticals used in the treatment of cancer and infectious diseases. The Company has one operating segment, being research and development.
Executives
Sarkis Meterissian Director